Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia

Haematologica

Volumn 99, Issue 3, 2014, Pages 430-436

  te Winkel, Mariël L ^a   Pieters, Rob ^a   Wind, Ernst Jan D ^a   Gert Bessems, J H J M ^a   van den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTICOAGULANT AGENT; ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ILOPROST; METHOTREXATE; PAMIDRONIC ACID; PREDNISONE; PROSTACYCLIN DERIVATIVE; ZOLEDRONIC ACID; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTHROPLASTY; BONE GRAFT; BONE NECROSIS; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HIP SURGERY; HUMAN; HYPERBARIC OXYGEN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOTOMY; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; X RAY; ADOLESCENT; CHILD; COMPLICATION; DISEASE MANAGEMENT; INFANT; META ANALYSIS; NEWBORN; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; HUMANS; INFANT; INFANT, NEWBORN; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84895730406     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.095562     Document Type: Review

References (93)

1. Barr RD, Sala A. Osteonecrosis in children and adolescents with cancer. Pediatr Blood Cancer. 2008;50(2 Suppl):483-6.
2. Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000;18(18):3262-72.
3. Sala A, Mattano LA Jr, Barr RD. Osteonecrosis in children and adolescents with cancer-an adverse effect of systemic therapy. Eur J Cancer. 2007;43(4):683-9.
4. Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066-72.
5. Symptomatic multifocal osteonecrosis. A multicenter study. Collaborative Osteonecrosis Group. Clin Orthop Relat Res. 1999(369):312-26.
6. te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica. 2008; 93(10):1570-4.
7. Bernbeck B, Mauz-Korholz C, Zotz RB, Gobel U. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis. Klin Padiatr. 2003;215(6):327-31.
8. Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia. 2008;22(2):308-12.
9. te Winkel ML, Pieters R, Hop WC, de Groot-Kruseman HA, Lequin MH, van der Sluis IM, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011;29(31):4143-50.
10. de Bont JM, Holt B, Dekker AW, van der Does-van den Berg A, Sonneveld P, Pieters R. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia. 2004;18(12):2032-5.
11. National Cancer Institute Common Terminology Criteria for adverse events, version 3.0. Aug. 2006. Available from: http://ctep.cancer.gov/protocolDevelopmen t.
12. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An endresult study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4): 737-55.
13. D'Aubigne RM, Postel M. Function al results of hip arthroplasty with acrylic prosthesis. J Bone Joint Surg Am. 1954;36-A(3):451-75.
14. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985;67(1):3-9.
15. ARCO (Association for Research on Osseous Circulation) Committee on Terminology and Staging. ARCO Newslett 1992;4:41-46.
16. Clar H, Pascher A, Kastner N, Gruber G, Robl T, Windhager R. Matrix-assisted autologous chondrocyte implantation into a 14cm(2) cartilage defect, caused by steroidinduced osteonecrosis. Knee. 2010;17(3): 255-7.
17. Greggio NA, Pillon M, Varotto E, Zanin A, Talenti E, Palozzo AC, et al. Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies. Case Report Med. 2010;2010:206132.
18. Muller I, Vaegler M, Holzwarth C, Tzaribatchev N, Pfister SM, Schutt B, et al. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis. Leukemia. 2008;22(11):2054-61.
19. Kotecha RS, Powers N, Lee SJ, Murray KJ, Carter T, Cole C. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL). Pediatr Blood Cancer. 2010;54(7):934-40.
20. Bernbeck B, Christaras A, Krauth K, Lentrodt S, Strelow H, Schaper J, et al. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygentherapy (HBO): an approach to cure?--BME/AON and hyperbaric oxygen therapy as a treatment modality. Klin Padiatr. 2004;216(6):370-8.
21. Gortz S, De Young AJ, Bugbee WD. Fresh osteochondral allografting for steroid-associated osteonecrosis of the femoral condyles. Clin Orthop Relat Res. 2010;468(5):1269-78.
22. Wells L, Hosalkar HS, Crawford EA, Agrawal N, Goebel J, Dormans JP. Thorough debridement under endoscopic visualization with bone grafting and stabilization for femoral head osteonecrosis in children. J Pediatr Orthop. 2009;29(4):319-26.
23. Nguyen T, Zacharin MR. Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes. J Pediatr Endocrinol Metab. 2006;19(2):161-7.
24. Jager M, Zilkens C, Westhoff B, Jelinek EM, Kozina G, Krauspe R. Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer. Anticancer Res. 2009;29(8):3433-40.
25. Karimova EJ, Rai SN, Wu J, Britton L, Kaste SC, Neel MD. Femoral resurfacing in young patients with hematologic cancer and osteonecrosis. Clin Orthop Relat Res. 2008;466(12):3044-50.
26. Leblicq C, Laverdiere C, Decarie JC, Delisle JF, Isler MH, Moghrabi A, et al. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(5):741-7.
27. Padhye B, Dalla-Pozza L, Little DG, Munns CF. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis. Pediatr Blood Cancer. 2013;60(9):1539-45.
28. Inoue K, Suenaga N, Oizumi N, Tanaka Y, Minami A. A vascularized scapular graft for juvenile osteonecrosis of the humeral head. J Shoulder Elbow Surg. 2012;21(4):e9-e13.
29. Sabharwal S, MacLeod R. Ilizarov hip reconstruction for the management of advanced osteonecrosis in an adolescent with leukemia. J Pediatr Orthop B. 2012;21(3): 252-9.
30. McQuade M, Houghton K. Use of bisphosphonates in a case of Perthes disease. Orthop Nurs. 2005;24(6):393-8.
31. Ramachandran M, Ward K, Brown RR, Munns CF, Cowell CT, Little DG. Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. J Bone Joint Surg Am. 2007;89(8):1727-34.
32. Hernigou P, Galacteros F, Bachir D, Goutallier D. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am. 1991;73(1):81-92.
33. Bernbeck B, Krauth KA, Scherer A, Engelbrecht V, Gobel U. Aseptic osteonecrosis in a child with nephroblastoma healed by hyperbaric oxygen therapy. Med Pediatr Oncol. 2002;39(1):47-8.
34. Scherer A, Engelbrecht V, Bernbeck B, May P, Willers R, Gobel U, et al. MRI evaluation of aseptic osteonecrosis in children over the course of hyperbaric oxygen therapy. Rofo. 2000;172(10):798-801.
35. Chan BK, Bell SN. Bilateral avascular necrosis of the humeral trochleae after chemotherapy. J Bone Joint Surg Br. 2000;82(5):670-2.
36. Yoshimura I, Naito M, Kanazawa K, Takeyama A, Karashima H, Ida T, et al. Arthroscopic treatment for an osteochondral defect of the talus after necrosis associated with acute lymphoblastic leukaemia: a case report. J Foot Ankle Surg. 2010;16(4):e88-90.
37. Styles LA, Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol. 1996;52(2): 103-7.
38. Guven M, Unay K, Bes C, Poyanli O, Akman B. Hip osteonecrosis in Cushing's disease treated with bone-preserving procedures. J Orthop Sci. 2009;14(5):662-5.
39. Lowrie AG, Rao K, Nanu A, Erdmann MW. Reversed flow lateral circumflex femoral vessels as recipients for free fibular grafting in treatment of femoral head osteonecrosis. Microsurgery. 2010;30(1):19-23.
40. Oh CW, Rodriguez A, Guille JT, Bowen JR. Labral support shelf arthroplasty for the early stages of severe Legg-Calve-Perthes disease. Am J Orthop (Belle Mead NJ). 2010;39(1):26-9.
41. Pecquery R, Laville JM, Salmeron F. Legg-Calve-Perthes disease treatment by augmentation acetabuloplasty. Orthop Traumatol Surg Res. 2010;96(2):166-74.
42. Conroy E, Sheehan E, P OC, Connolly P, McCormack D. Triple pelvic osteotomy in Legg-Calve-Perthes disease using a single anterolateral incision: a 4-year review. J Pediatr Orthop B. 2010;19(4):323-6.
43. Notzli HP, Chou LB, Ganz R. Open-reduction and intertrochanteric osteotomy for osteonecrosis and extrusion of the femoral head in adolescents. J Pediatr Orthop. 1995;15(1):16-20.
44. Sponer P, Kucera T. Remodelling of the femoral head after proximal femoral osteotomy for avascular necrosis associated with slipped capital femoral epiphysis. Bratisl Lek Listy. 2010;111(7):410-3.
45. Beer Y, Smorgick Y, Oron A, Mirovsky Y, Weigl D, Agar G, et al. Long-term results of proximal femoral osteotomy in Legg-Calve-Perthes disease. J Pediatr Orthop. 2008;28(8): 819-24.
46. Sanchez Mesa PA, Yamhure FH. Percutaneous innominate pelvic osteotomy without the use of bone graft for femoral head coverage in children 2-8 years of age. J Pediatr Orthop B. 2010;19(3):256-63.
47. Shah H, Siddesh ND, Joseph B, Nair SN. Effect of prophylactic trochanteric epiphyseodesis in older children with Perthes' disease. J Pediatr Orthop. 2009;29(8):889-95.
48. Kim HK, da Cunha AM, Browne R, Kim HT, Herring JA. How much varus is optimal with proximal femoral osteotomy to preserve the femoral head in Legg-Calve-Perthes disease? J Bone Joint Surg Am. 2011;93(4):341-7.
49. Minagawa H, Aiga A, Endo H, Mitani S, Tetsunaga T, Ozaki T. Radiological and clinical results of rotational acetabular osteotomy combined with femoral intertrochanteric osteotomy for avascular necrosis following treatment for developmental dysplasia of the hip. Acta Med Okayama. 2009;63(4):169-75.
50. Kucukkaya M, Kabukcuoglu Y, Ozturk I, Kuzgun U. Avascular necrosis of the femoral head in childhood: the results of treatment with articulated distraction method. J Pediatr Orthop. 2000;20(6):722-8.
51. Sudesh P, Bali K, Mootha AK, Dhillon MS, Saini R. Arthrodiastasis and surgical containment in severe late-onset Perthes disease: an analysis of 14 patients. Acta Orthop Belg. 2010;76(3):329-34.
52. Bizot P, Witvoet J, Sedel L. Avascular necrosis of the femoral head after allogenic bonemarrow transplantation. A retrospective study of 27 consecutive THAs with a minimal two-year follow-up. J Bone Joint Surg Br. 1996;78(6):878-83.
53. Iwai S, Sato K, Nakamura T, Okazaki M, Itoh Y, Toyama Y, et al. Costo-osteochondral graft for post-traumatic osteonecrosis of the radial head in an adolescent boy. J Bone Joint Surg Br. 2011;93(1):111-4.
54. Anderson LA, Erickson JA, Severson EP, Peters CL. Sequelae of Perthes disease: treatment with surgical hip dislocation and relative femoral neck lengthening. J Pediatr Orthop. 2010;30(8):758-66.
55. Bowen JR, Guille JT, Jeong C, Worananarat P, Oh CW, Rodriquez A, et al. Labral support shelf arthroplasty for containment in early stages of Legg-Calve-Perthes disease. J Pediatr Orthop. 2011;31(2 Suppl):S206-11.
56. Citlak A, Kerimoglu S, Baki C, Aydin H. Comparison between conservative and surgical treatment in Perthes disease. Arch Orthop Trauma Surg. 2012;132(1):87-92.
57. Eamsobhana P, Kaewpornsawan K. Combined osteotomy in patients with severe Legg-Calve-Perthes disease. J Med Assoc Thai. 2012;95 (Suppl 10):S128-34.
58. Finkbone PR, Severson EP, Cabanela ME, Trousdale RT. Ceramic-on-ceramic total hip arthroplasty in patients younger than 20 years. J Arthroplasty. 2012;27(2):213-9.
59. Froberg L, Christensen F, Pedersen NW, Overgaard S. The need for total hip arthroplasty in Perthes disease: a long-term study. Clin Orthop Relat Res. 2011;469(4):1134-40.
60. Kamath AF, Sheth NP, Hosalkar HH, Babatunde OM, Lee GC, Nelson CL. Modern total hip arthroplasty in patients younger than 21 years. J Arthroplasty. 2012;27(3):402-8.
61. Kim HT, Gu JK, Bae SH, Jang JH, Lee JS. Does valgus femoral osteotomy improve femoral head roundness in severe Legg-Calve-Perthes disease? Clin Orthop Relat Res. 2013;471(3):1021-7.
62. Nakashima Y, Kubota H, Yamamoto T, Mawatari T, Motomura G, Iwamoto Y. Transtrochanteric rotational osteotomy for late-onset Legg-Calve-Perthes disease. J Pediatr Orthop. 2011;31(2 Suppl):S223-8.
63. Volpon JB. Comparison between innominate osteotomy and arthrodistraction as a primary treatment for Legg-Calve-Perthes disease: a prospective controlled trial. Int Orthop. 2012;36(9):1899-905.
64. Wright DM, Perry DC, Bruce CE. Shelf acetabuloplasty for Perthes disease in patients older than eight years of age: an observational cohort study. J Pediatr Orthop B. 2013;22(2):96-100.
65. Zhang CQ, Sun Y, Chen SB, Jin DX, Sheng JG, Cheng XG, et al. Free vascularised fibular graft for post-traumatic osteonecrosis of the femoral head in teenage patients. J Bone Joint Surg Br. 2011;93(10):1314-9.
66. Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, et al. Acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2002:162-92.
67. Teuffel O, Kuster SP, Hunger SP, Conter V, Hitzler J, Ethier MC, et al. Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia. 2011;25(8):1232-8.
68. Mattano L. The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant. 2003;7 (Suppl 3):71-5.
69. McNeer JL, Nachman JB. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol. 2010;149(5):638-52.
70. Fan C, Foster BK, Wallace WH, Xian CJ. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Curr Mol Med. 2011;11(2):140-51.
71. Vrooman LM, Stevenson KE, Supko JG, O'Brien J, Dahlberg SE, Asselin BL, et al. Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli LAsparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol. 2013; 31(9):1202-10.
72. Mattano LA Jr, Nachman JB, Devidas M, Winick N, Raetz E, Carroll WL, et al. Increased Incidence of Osteonecrosis (ON) with a Dexamethasone (DEX) Induction for High Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report from the Children's Oncology Group (COG). ASH Annual Meeting Abstracts. 2008;112(11):898-.
73. Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101(10):3809-17.
74. Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129(6):734-45.
75. Moricke A, Zimmermann M, Schrauder A, Stanulla M, Schmid H, Fengler R, et al. No Influence on the Incidence of Osteonecroses When Dexamethasone Replaces Prednisone during Induction Treatment for Childhood ALL: Results of Trial ALL-BFM 2000. ASH Annual Meeting Abstracts. 2008;112 (11):899.
76. Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, et al. No advantage of dexamethasone over prednisolone for the outcome of standard-and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol. J Clin Oncol. 2005;23(27): 6489-98.
77. Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88(7):747-53.
78. Girard P, Auquier P, Barlogis V, Contet A, Poiree M, Demeocq F, et al. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica. 2013;98(7):1089-97.
79. Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117(8): 2340-7.
80. Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Leukemia. 1998;12 (9):1344-8.
81. Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br J Haematol. 2000;110(4):813-8.
82. van den Heuvel-Eibrink MM, Pieters R. Steroids and risk of osteonecrosis in ALL: take a break. Lancet Oncol. 2012;13(9):855-7.
83. Yang L, Boyd K, Kaste SC, Kamdem Kamdem L, Rahija RJ, Relling MV. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res. 2009;27(2):169-75.
84. Mattano LA Jr, Devidas M, Nachman JB, Sather HN, Hunger SP, Steinherz PG, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-15.
85. Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008;111(5):2548-55.
86. Ghosh J, Manjunatha YC, Thulkar S, Bakhshi S. Avascular necrosis of femoral head in childhood acute myeloid leukemia: complication of chemotherapy without steroids. Pediatr Blood Cancer. 2008;51(2): 308-9.
87. Kaspers GJ, Veerman AJ, Popp-Snijders C, Lomecky M, Van Zantwijk CH, Swinkels LM, et al. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;27(2): 114-21.
88. Johannesen J, Briody J, McQuade M, Little DG, Cowell CT, Munns CF. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Bone. 2009;45(5):898-902.
89. Letson GD, D'Ambrosia RD, Aguilar EA, Wagespack A. Activity relationships of total hip arthroplasty in patients with osteonecrosis and osteoarthritis. Orthopedics. 1996;19 (8):665-8.
90. Mitchell MD, Kundel HL, Steinberg ME, Kressel HY, Alavi A, Axel L. Avascular necrosis of the hip: comparison of MR, CT, and scintigraphy. AJR Am J Roentgenol. 1986; 147(1):67-71.
91. Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol. 2007;25(12):1525-31.
92. Karimova EJ, Rai SN, Ingle D, Ralph AC, Deng X, Neel MD, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR Am J Roentgenol. 2006;186(2): 477-82.
93. Madadi F, Shamsian BS, Alavi S, Eajazi A, Aslani A. Avascular necrosis of the femoral head in children with acute lymphoblastic leukemia: a 4-to 9-year follow-up study. Orthopedics. 2011;34(10):e593-7.